Robust immunoscore model to predict the response to anti-PD1 therapy in melanoma.

Aging (Albany NY) · 2019 · PMC6932919 · PMID 31796647

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

a robust trend toward significanceP = 0.059so close (0.05 < p ≤ 0.1)

The 1-year PFS was 42.4% (95% confidence interval (CI) 20.6%-87.2%) in the high-immunoscore group and 14.3% (95% CI 4.0%-51.5%) in the low-immunoscore group; the PFS difference showed a robust trend toward significance (HR 0.39, 95% CI 0.14-1.06; P = 0.059; Figure 3B ).

also in 2 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.